Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Cash from Financing
$-7,172 Mil (TTM As of Mar. 2015)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2015, GlaxoSmithKline PLC paid $52 Mil more to buy back shares than it received from issuing new shares. It spent $964 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $1,442 Mil paying cash dividends to shareholders. It spent $205 Mil on other financial activities. In all, GlaxoSmithKline PLC spent $2,664 Mil on financial activities for the three months ended in Mar. 2015.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

GlaxoSmithKline PLC's Cash from Financing for the fiscal year that ended in Dec. 2014 is calculated as:

Cash from Financing(A: Dec. 2014 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-259.780907668+392.801251956+0+-6334.89827856+-2225.35211268
=-8,427

GlaxoSmithKline PLC's Cash from Financing for the quarter that ended in Mar. 2015 is

Cash from Financing(Q: Mar. 2015 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-52.3168908819+-964.125560538+0+-1442.45142003+-204.783258595
=-2,664

GlaxoSmithKline PLC Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2015 was -1612.52115059 (Jun. 2014 ) + -293.159609121 (Sep. 2014 ) + -2602.50391236 (Dec. 2014 ) + -2663.67713004 (Mar. 2015 ) = $-7,172 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

GlaxoSmithKline PLC's net issuance of stock for the three months ended in Mar. 2015 was $-52 Mil. GlaxoSmithKline PLC paid $52 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

GlaxoSmithKline PLC's net issuance of debt for the three months ended in Mar. 2015 was $-964 Mil. GlaxoSmithKline PLC spent $964 Mil paying down its debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

GlaxoSmithKline PLC's net issuance of preferred for the three months ended in Mar. 2015 was $0 Mil. GlaxoSmithKline PLC paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

GlaxoSmithKline PLC's cash flow for dividends for the three months ended in Mar. 2015 was $-1,442 Mil. GlaxoSmithKline PLC spent $1,442 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

GlaxoSmithKline PLC's other financing for the three months ended in Mar. 2015 was $-205 Mil. GlaxoSmithKline PLC spent $205 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Net Issuance of Stock -1,186-1,730-6,494-5,429-298-3,014-3,418-1,578-260
Net Issuance of Debt 32-1,5189,8273,5901,961-2,083-25,83867393
Net Issuance of Preferred 0000000000
Dividends -4,171-5,102-5,636-4,470-4,875-5,184-5,679-6,162-6,412-6,335
Other Financing 239-1,062-1,210-984-1,588-1,523-1,028-1,672-2,344-2,225
Cash from Financing -5,084-9,412-3,513-7,293-4,503-8,691-9,722-5,414-10,267-8,427

GlaxoSmithKline PLC Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
Net Issuance of Stock -89848-22-754-831-35-298-1159-52
Net Issuance of Debt 1,087229-944630169-1,4851,1681,485-715-964
Net Issuance of Preferred 0000000000
Dividends -1,069-1,312-1,653-1,765-1,424-1,590-1,780-1,769-1,491-1,442
Other Financing -740-1,160-628135-560-1,191-7022-455-205
Cash from Financing -1,620-2,195-3,248-1,754-2,646-4,301-1,613-293-2,603-2,664
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK